Works matching IS 1792-0981 AND VI 16 AND IP 3 AND DT 2018


Results: 79
    1
    2
    3

    Efficacy and tolerability of interferon-free regimen for patients with genotype-1 HCV infection.

    Published in:
    Experimental & Therapeutic Medicine, 2018, v. 16, n. 3, p. 2743, doi. 10.3892/etm.2018.6481
    By:
    • Takeda, Kosuke;
    • Noguchi, Ryuichi;
    • Namisaki, Tadashi;
    • Moriya, Kei;
    • Akahane, Takemi;
    • Kitade, Mitsuteru;
    • Kawaratani, Hideto;
    • Shimozato, Naotaka;
    • Kaji, Kosuke;
    • Takaya, Hiroaki;
    • Sawada, Yasuhiko;
    • Seki, Kenichiro;
    • Fujinaga, Yukihisa;
    • Tsuji, Yuki;
    • Kubo, Takuya;
    • Sato, Shinya;
    • Saikawa, Soichiro;
    • Nakanishi, Keisuke;
    • Furukawa, Masanori;
    • Kitagawa, Koh
    Publication type:
    Article
    4
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    CORRIGENDUM.

    Published in:
    2018
    By:
    • Sai, Yi-Pa;
    • Song, Yuan-Chun;
    • Chen, Xing-Xing;
    • Luo, Xuan;
    • Liu, Jing;
    • Cui, Wei-Jing
    Publication type:
    Correction Notice
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Reduced hepcidin level features osteoporosis.

    Published in:
    Experimental & Therapeutic Medicine, 2018, v. 16, n. 3, p. 1963, doi. 10.3892/etm.2018.6410
    By:
    • Liu, Bin;
    • Liu, Caihua;
    • Zhong, Weifeng;
    • Song, Min;
    • Du, Shouqin;
    • Su, Jianli
    Publication type:
    Article
    46
    47
    48
    49
    50